[HTML][HTML] Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation

M Cavaille-Coll, S Bala, E Velidedeoglu… - American journal of …, 2013 - Elsevier
Abstract The Food and Drug Administration (FDA) held an open public workshop in
September 2011 to discuss the current state of science related to the effects of ischemia
reperfusion injury (IRI) on outcomes in kidney transplantation. Topics included the
development of IRI and delayed graft function (DGF), histology and biomarkers, donor
factors, recipient factors, organ quality and organ preservation by means of cold storage
solutions or machine perfusion. Various mechanisms of injury and maladaptive response to …